Cardiac apoptosis induced under high glucose condition involves activation of IGF2R signaling in H9c2 cardiomyoblasts and streptozotocin-induced diabetic rat hearts

Chih Chung Feng, Sudhir Pandey, Ching Yuang Lin, Chia Yao Shen, Ruey Lin Chang, Tung Ti Chang, Ray Jade Chen, Vijaya Padma Viswanadha, Yueh Min Lin, Chih Yang Huang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The insulin-like growth factor type 2 receptor (IGF2R) overexpression has been implicated in heart disease progression. Unregulated IGF2R signaling triggers cardiac hypertrophy, apoptosis, and cardiomyopathies. The present study investigated the role of IGF2R in cardiomyocyte apoptosis under high glucose (HG) levels and in streptozotocin (STZ) induced diabetic rat hearts. We found that IGF2 and IGF2R protein expression were highly upregulated under high glucose condition in H9c2 cells as well as in STZ induced diabetic rat hearts. Using immunoblotting and TUNEL assay, we found that elevated glucose condition induced IGF2R expression leads to activation of Gαq mediated calcineurin-dependent signaling pathway, which further leads to downstream activation and expression of cardiac hypertrophy related proteins, ANP and BNP. Further, we found that glucose-induced IGF2R expression downregulated survival protein p-Akt, p-Bad (Ser 155) and enhanced the expression of apoptosis-inducing proteins cytochrome c and cleaved Caspase-3. Our results suggested that hyperglycemic condition leads to cellular cardiomyocyte apoptosis both in vitro and in vivo models, via abnormally increased activation of the IGF2R signaling pathway.

Original languageEnglish
Pages (from-to)880-885
Number of pages6
JournalBiomedicine and Pharmacotherapy
Volume97
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

IGF Type 2 Receptor
Streptozocin
Apoptosis
Glucose
Cardiomegaly
Cardiac Myocytes
Apoptosis Regulatory Proteins
Proteins
Calcineurin
In Situ Nick-End Labeling
Atrial Natriuretic Factor
Cytochromes c
Cardiomyopathies
Immunoblotting
Caspase 3
Disease Progression
Heart Diseases
Down-Regulation

Keywords

  • Apoptosis
  • Diabetic hyperglycemic
  • High glucose (HG)
  • IGF2R

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cardiac apoptosis induced under high glucose condition involves activation of IGF2R signaling in H9c2 cardiomyoblasts and streptozotocin-induced diabetic rat hearts. / Feng, Chih Chung; Pandey, Sudhir; Lin, Ching Yuang; Shen, Chia Yao; Chang, Ruey Lin; Chang, Tung Ti; Chen, Ray Jade; Viswanadha, Vijaya Padma; Lin, Yueh Min; Huang, Chih Yang.

In: Biomedicine and Pharmacotherapy, Vol. 97, 01.01.2018, p. 880-885.

Research output: Contribution to journalArticle

Feng, Chih Chung ; Pandey, Sudhir ; Lin, Ching Yuang ; Shen, Chia Yao ; Chang, Ruey Lin ; Chang, Tung Ti ; Chen, Ray Jade ; Viswanadha, Vijaya Padma ; Lin, Yueh Min ; Huang, Chih Yang. / Cardiac apoptosis induced under high glucose condition involves activation of IGF2R signaling in H9c2 cardiomyoblasts and streptozotocin-induced diabetic rat hearts. In: Biomedicine and Pharmacotherapy. 2018 ; Vol. 97. pp. 880-885.
@article{c7107cc97c1b43568c64946c2a37f06d,
title = "Cardiac apoptosis induced under high glucose condition involves activation of IGF2R signaling in H9c2 cardiomyoblasts and streptozotocin-induced diabetic rat hearts",
abstract = "The insulin-like growth factor type 2 receptor (IGF2R) overexpression has been implicated in heart disease progression. Unregulated IGF2R signaling triggers cardiac hypertrophy, apoptosis, and cardiomyopathies. The present study investigated the role of IGF2R in cardiomyocyte apoptosis under high glucose (HG) levels and in streptozotocin (STZ) induced diabetic rat hearts. We found that IGF2 and IGF2R protein expression were highly upregulated under high glucose condition in H9c2 cells as well as in STZ induced diabetic rat hearts. Using immunoblotting and TUNEL assay, we found that elevated glucose condition induced IGF2R expression leads to activation of Gαq mediated calcineurin-dependent signaling pathway, which further leads to downstream activation and expression of cardiac hypertrophy related proteins, ANP and BNP. Further, we found that glucose-induced IGF2R expression downregulated survival protein p-Akt, p-Bad (Ser 155) and enhanced the expression of apoptosis-inducing proteins cytochrome c and cleaved Caspase-3. Our results suggested that hyperglycemic condition leads to cellular cardiomyocyte apoptosis both in vitro and in vivo models, via abnormally increased activation of the IGF2R signaling pathway.",
keywords = "Apoptosis, Diabetic hyperglycemic, High glucose (HG), IGF2R",
author = "Feng, {Chih Chung} and Sudhir Pandey and Lin, {Ching Yuang} and Shen, {Chia Yao} and Chang, {Ruey Lin} and Chang, {Tung Ti} and Chen, {Ray Jade} and Viswanadha, {Vijaya Padma} and Lin, {Yueh Min} and Huang, {Chih Yang}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.biopha.2017.11.020",
language = "English",
volume = "97",
pages = "880--885",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - Cardiac apoptosis induced under high glucose condition involves activation of IGF2R signaling in H9c2 cardiomyoblasts and streptozotocin-induced diabetic rat hearts

AU - Feng, Chih Chung

AU - Pandey, Sudhir

AU - Lin, Ching Yuang

AU - Shen, Chia Yao

AU - Chang, Ruey Lin

AU - Chang, Tung Ti

AU - Chen, Ray Jade

AU - Viswanadha, Vijaya Padma

AU - Lin, Yueh Min

AU - Huang, Chih Yang

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The insulin-like growth factor type 2 receptor (IGF2R) overexpression has been implicated in heart disease progression. Unregulated IGF2R signaling triggers cardiac hypertrophy, apoptosis, and cardiomyopathies. The present study investigated the role of IGF2R in cardiomyocyte apoptosis under high glucose (HG) levels and in streptozotocin (STZ) induced diabetic rat hearts. We found that IGF2 and IGF2R protein expression were highly upregulated under high glucose condition in H9c2 cells as well as in STZ induced diabetic rat hearts. Using immunoblotting and TUNEL assay, we found that elevated glucose condition induced IGF2R expression leads to activation of Gαq mediated calcineurin-dependent signaling pathway, which further leads to downstream activation and expression of cardiac hypertrophy related proteins, ANP and BNP. Further, we found that glucose-induced IGF2R expression downregulated survival protein p-Akt, p-Bad (Ser 155) and enhanced the expression of apoptosis-inducing proteins cytochrome c and cleaved Caspase-3. Our results suggested that hyperglycemic condition leads to cellular cardiomyocyte apoptosis both in vitro and in vivo models, via abnormally increased activation of the IGF2R signaling pathway.

AB - The insulin-like growth factor type 2 receptor (IGF2R) overexpression has been implicated in heart disease progression. Unregulated IGF2R signaling triggers cardiac hypertrophy, apoptosis, and cardiomyopathies. The present study investigated the role of IGF2R in cardiomyocyte apoptosis under high glucose (HG) levels and in streptozotocin (STZ) induced diabetic rat hearts. We found that IGF2 and IGF2R protein expression were highly upregulated under high glucose condition in H9c2 cells as well as in STZ induced diabetic rat hearts. Using immunoblotting and TUNEL assay, we found that elevated glucose condition induced IGF2R expression leads to activation of Gαq mediated calcineurin-dependent signaling pathway, which further leads to downstream activation and expression of cardiac hypertrophy related proteins, ANP and BNP. Further, we found that glucose-induced IGF2R expression downregulated survival protein p-Akt, p-Bad (Ser 155) and enhanced the expression of apoptosis-inducing proteins cytochrome c and cleaved Caspase-3. Our results suggested that hyperglycemic condition leads to cellular cardiomyocyte apoptosis both in vitro and in vivo models, via abnormally increased activation of the IGF2R signaling pathway.

KW - Apoptosis

KW - Diabetic hyperglycemic

KW - High glucose (HG)

KW - IGF2R

UR - http://www.scopus.com/inward/record.url?scp=85032790184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032790184&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2017.11.020

DO - 10.1016/j.biopha.2017.11.020

M3 - Article

C2 - 29136764

AN - SCOPUS:85032790184

VL - 97

SP - 880

EP - 885

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

ER -